Decreased tyrosine transport in fibroblasts from schizophrenics: Implications for membrane pathology

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 1-2, 1996, Pages 59-64

  Ramchand, C N ^a,b   Peet, M ^a   Clark, A E ^c   Gliddon, A E ^c   Hemmings, G P ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b BANGOR UNIVERSITY   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; TYROSINE;

ADULT; AMINO ACID TRANSPORT; CELL KINETICS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; LIPID METABOLISM; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SKIN FIBROBLAST;

GYMNOMYZA SAMOENSIS;

EID: 0029779689     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90146-5     Document Type: Conference Paper

References (38)

1. Pickar D., Breier A., Kelsoe J. Plasma homovanillic acid as an index of central dopaminergic activity: Studies in schizophrenic patients. Ann NY Acad Sci 1988; 339-346.
2. Carlsson A. Anti-psychotic drugs, neurotransmitter and schizophrenia. Am J Psychiatr 1978; 135: 164-173.
3. Baldessarini R. J., Frankenburg F. R. Clozapine: A novel antipsychotic agent. N Engl J Med 1991; 324: 746-754.
4. Hitzemann R., Hirschowitz J., Carver D. Membrane abnormalities in the psychosis and affective disorders. J Psychiatr Res 1984; 18: 319-326.
5. 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatr 1991; 48: 563-568.
6. Rybakowski J. K., Lehmann W. Abnormalities of lithium transport across the erythrocyte membrane in depression and schizophrenia. Biol Psychiatr 1991;
7. Bates C., Horrobin D. F., Ells K. Fatty acids in plasma phospholipids and cholesterol esters from identical twins concordant and discordant for schizophrenia. Schizophr Res 1992; 6: 1-7.
8. Pangrel A. M., Steudle A., Jaroni H. W., Rufer R., Gattaz W. F. Increased platelet membrane lysophosphatydylcholine in schizophrenia. Biol Psychiatr 1991; 30: 837-840.
9. Kaiya H., Horrobin D. F., Manku M. S,. Morse-Fisher N. Essential and other fatty acids in plasma in Schizophrenics and normal individuals from Japan. Biol Psychiatr 1991; 30: 357-362
10. Horrobin D. F., Manku M. S., Morse-Fisher N., Vaddadi K. S. Essential fatty acids in plasma phospholipids in schizophrenics. Biol Psychiatr 1989; 25: 262-268.
11. Horrobin D. F., Manku M. S., Glen A. I. M. Fatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatr 1991; 30: 795-805.
12. Borg J., Edstrom L., Bjerkenstet L. et al. Muscle biopsy findings, conduction velocity and refractory period of single motor nerve fibres in schizophrenia. J Neurol Neurosurg Psychiatr 1987; 50: 1655-1644.
13. Naponen M., Sanfilipo M., Samanich K. et al. Elevated PLA2 activity in schizophrenics and other psychiatric patients. Biol Psychiatr 1993; 34: 641-649.
14. Horrobin D. F., Ally A. I., Karmali R. A. et al. Prostaglandin and schizophrenia. Further discussion of the evidence. Psychol Med 1978; 8: 43-48.
15. Ramchand C. N., Tressman R. L., Griffiths K. D., Davies J. I. Changes in erythrocyte membrane permeability associated with neuroleptic medication in schizophrenic patients. Schizophr Res 1992; 6: 119.
16. Mahadik S. P., Mukherjee S., Laev H., Reddy R., Schnur D. B. Abnormal growth of skin fibroblasts from schizophrenic patients. Psychiatr Res 1991; 37: 309-320.
17. Hagenfeldt L., Venizelos N., Bjerkenstedt L., Wiesel F.-A. Decreased tyrosine transport in fibroblasts from schizophrenic patients. Life Sci 1987; 41: 2749-2757.
18. Ramchand C. N., Das I., Gliddon A., Hirsch S. R. Role of polyamines in the membrane pathology of schizophrenia. A study using fibroblasts from schizophrenic patients and normal controls. Schizophr Res 1994;
19. Ramchand C. N., Clark A. E., Gliddon A. E., Hemmings G. P. Glucose metabolism and monoamine oxidase activity from fibroblasts of schizophrenic patients and controls Life Sci 1994; 13: 249-253.
20. Hitzemann R., Hirschowitz J., Garver D. Membrane abnormalities in the psychoses and affective disorders. J Psychiatr Res 1984; 18: 319-326.
21. Meltzer H. Y. Is there a specific membrane defect in bipolar disorders. Biol Psychiatr 1991; 30: 1071-1074.
22. Bjerkenstedt L., Edman G., Hagenfeldt L., Sedvall G., Wiesel F.-A. Plasma amino-acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatr 1985; 147: 276-282.
23. Wei J., Ramchand C. N., Hemmings G. P. Low concentrations of serum tyrosine in neuroleptic-free schizophrenic patients with an early onset. Schizophr Res 1994;
24. Weisel F. A., Venizelos N., Bjerkenstedt L., Hagenfeldt L. Tyrosine transport in schizophrenia. Schizophr Res 1994; 13: 255-258.
25. Gazzola G. C., Dall'Asta V., Franchi-Gazzola R., White M. F. The cluster-tray method for rapid solute fluxes in adherent cultured cells. Anal Biochem 1981; 115: 368-374.
26. Lowry O. H., Rosenbrough N. J., Farr H. L., Randall R. J. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
27. Roath J. A., Breakefield X. O., Castiglione C. M. Monoamine oxidase and catechol-O-methyl transferase activities in cultured human skin fibroblasts. Life Sci 1976; 19: 1705-1710.
28. Sims N. R., Finegan M., Blass J. P. Altered metabolic properties of cultured skin fibroblasts in Alzheimers disease. Ann Neurol 1987; 21: 451-457.
29. Groshong R., Baldessarini R. J., Gibson D. N. Activities of type A and B MAO and catechol-O-methyl transferase in blood cells and skin fibroblasts of normal and chronic schizophrenic subjects. Arch Gen Psychiatr 1978; 35: 1198-1205.
30. Lopez-Burillo S., Garcia-Sancho J., Herreros B. Tryptophan transport through transport system T in the human-one-E erythrocyte the Ehrlich cell and the rat intestine membrane. Biochim Biophys Acta 1985; 820: 85-94.
31. Christensen H. N. ed. Biological transport. Reading: Benjamin W. A. Inc., 1975.
32. Nunez E. A. Fatty acids and cell signalling. Prostaglandins Leukot Essent Fatty Acids 1993; 48: 1-22.
33. Horrobin D. F., Glen A. I. M., Vaddadi K. The membrane hypothesis of schizophrenia. Schizophr Res 1994; 13: 195-207.
34. Schuber S. Influence of polyamines on membrane functions. Biochem J 1989; 260: 1-10.
35. Tabor C. W., Tabor H. Polyamines. Annu Rev Biochem 1984; 53: 749-790.
36. Pegg A. E., McCann P. P. Polyamine metabolism and function. Am J Physiol 1982; 243: C212-221.
37. Keshavan M. S., Mallinger A. G., Pettegrew J. W., Dippold C. Erythrocyte membrane phospholipid in psychotic patients. Psychiatr Res 1993; 49: 89-95.
38. Horrobin D. F., Glen A. I. M., Skinner F. Red cell membrane fattyacids in schizophrenic patients with mainly positive or mainly negative symptoms. Schizophr Res 1993; 9: 221-227